[Federal Register Volume 61, Number 206 (Wednesday, October 23, 1996)]
[Notices]
[Page 55074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-27081]



[[Page 55073]]


_______________________________________________________________________

Part II





Department of Health and Human Services





_______________________________________________________________________



Office of the Secretary



_______________________________________________________________________



Announcement of the Establishment of the Advisory Committee on Blood 
Safety and Availability and Request for Nominations for Members of the 
Committee; Notice

  Federal Register / Vol. 61, No. 206 / Wednesday, October 23, 1996 / 
Notices  

[[Page 55074]]



DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Announcement of the Establishment of the Advisory Committee on 
Blood Safety and Availability and Request for Nominations for Members 
of the Committee

AGENCY: Office of the Secretary, DHHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Office of the Secretary announces the establishment by the 
Secretary, October 9, 1996, of the Advisory Committee on Blood Safety 
and Availability (ACBSA). In addition, the Office of the Secretary 
requests nominations for representatives to serve on the ACBSA in 
accordance with its charter. Initial appointments of representatives 
shall be made for staggered terms of two to four years.

DATES: All nominations must be received at the address below by no 
later than 4:00 PM EDT on November 13, 1996.

ADDRESSES: All nomination packages shall be submitted to Eric Goosby, 
M.D., Office of Public Health and Science, Department of Health and 
Human Services, Room 736 E, 200 Independence Ave. S.W., Washington, DC 
20201.

FOR FURTHER INFORMATION CONTACT: Linda A. Smallwood, Ph.D., Center for 
Biologics Evaluation and Research, HFM-350, Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852. Tel (301) 
827-3514.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act, Public Law 92-493 as amended (5 U.S.C. App.2), and section 222 of 
the Public Health Service Act as amended (42 U.S.C. 217a), the Office 
of the Secretary announces establishment by the Secretary of the 
following Federal advisory committee:

Purpose

    The Committee will provide advice to the Secretary and the 
Assistant Secretary for Health on a range of issues which include: (1) 
the implications for blood safety and availability of various economic 
factors affecting product cost and supply; (2) definition of public 
health parameters around safety and availability of the blood supply; 
and (3) broad public health, ethical, and legal issues related to 
safety of the blood supply.
    Authority for the committee shall expire on October 9, 1998, unless 
the Secretary of Health and Human Services, with the concurrence of the 
Committee Management Secretariat, General Services Administration, 
determines that the continuance is in the public interest.

Nominations

    Persons nominated for membership should be from among authorities 
knowledgeable in blood banking, transfusion medicine, bioethics and 
related disciplines. Members shall be selected from among State and 
local organizations, the blood and blood products industry including 
manufacturers and distributors, advocacy groups, consumer advocates, 
provider organizations, academic researchers, ethicists, private 
physicians, behavioral scientists, legal organizations, and from 
communities of persons who are frequent recipients of blood and blood 
products.
    Members shall be invited to serve for overlapping terms: terms of 
more than two years are contingent upon the renewal of the committee by 
appropriate action prior to its expiration. Of the first members 
appointed, excluding the non-voting ex officio members, six shall serve 
for a term of two years, six for a term of three years, and six for a 
term of four years, as designated at the time of appointment.

Information Required

    Each nomination shall consist of a package that at minimum 
includes:
    A. A letter of nomination that clearly states the name and 
affiliation of the nominee, the nominator's basis for the nomination, 
the category for which the person is nominated, and a statement that 
the nominee is willing to serve as a member of the Committee;
    B. The name, return address, and daytime telephone number at which 
the nominator may be contacted, and the address and telephone number 
for the individual being nominated. Organizational nominators must 
identify a principal contact person in addition to contact information;
    C. A copy of the nominee's curriculum vitae.
    All nomination information for a nominee must be provided in a 
complete single package. Incomplete nominations cannot be considered. 
Nomination materials must bear original signatures and facsimile 
transmissions or copies are not acceptable.
Philip R. Lee,
Assistant Secretary for Health.
[FR Doc. 96-27081 Filed 10-22-96; 8:45 am]
BILLING CODE 4160-17-M